DEWPOINT THERAPEUTICS

dewpoint-therapeutics-logo

Dewpoint Therapeutics is a biotech company developing a drug platform that targets biomolecular condensates. Its technology uses machine-learning-based image analysis tools for visualizing condensates and offers an engine for genetically linked condensatopathy which is a collection of engineered cell lines with trackable condensates to prevent harmful protein sequestration, helping healthcare providers to have access to new therapies to address unmet needs. The company was founded in 2018 and is headquartered in Boston, Massachusetts.

#SimilarOrganizations #People #Financial #Event #Website #More

DEWPOINT THERAPEUTICS

Social Links:

Industry:
Biotechnology Life Science Medical Therapeutics

Founded:
2018-01-01

Address:
Boston, Massachusetts, United States

Country:
United States

Website Url:
http://www.dewpointx.com

Total Employee:
101+

Status:
Active

Email Addresses:
[email protected]

Total Funding:
287 M USD

Technology used in webpage:
SPF Microsoft Exchange Online Amazon Office 365 Mail Microsoft Azure DNS Sectigo SSL Sectigo Domain SSL Pound Sterling Japanese Yen MailChimp SPF


Similar Organizations

aerovate-therapeutics-logo

Aerovate Therapeutics

Aerovate Therapeutics is a biotechnology company focused on developing drugs for rare cardiopulmonary disease.

enliven-therapeutics-logo

Enliven Therapeutics

Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.

intergalactic-therapeutics-logo

Intergalactic Therapeutics

Intergalactic Therapeutics is an ATP company, is revolutionizing gene therapies with a novel non-viral platform.

remix-therapeutics-logo

Remix Therapeutics

Remix Therapeutics is a biotechnology company.

seismic-therapeutic-logo

Seismic Therapeutic

Seismic Therapeutic is a biotechnology company advancing machine learning for immunology drug development.

simcha-therapeutics-logo

Simcha Therapeutics

Simcha Therapeutics is a biopharmaceutical company developing engineered cytokine immunotherapy for cancer.


Current Advisors List

ambar-bhattacharyya_image

Ambar Bhattacharyya Series B Investor and Board Observer @ Dewpoint Therapeutics
Board_observer
2020-09-01

jurg-eckhardt_image

Jurg Eckhardt Board Member @ Dewpoint Therapeutics
Board_member
2019-11-01

giuseppe-ciaramella_image

Giuseppe Ciaramella Board Member @ Dewpoint Therapeutics
Board_member
2020-09-01

amir-nashat_image

Amir Nashat Board Member @ Dewpoint Therapeutics
Board_member

mark-murcko_image

Mark Murcko Member of the Board of Directors @ Dewpoint Therapeutics
Board_member
2018-11-01

Current Employees Featured

richard-young_image

Richard Young
Richard Young Co-Founder @ Dewpoint Therapeutics
Co-Founder

anthony-hyman_image

Anthony Hyman
Anthony Hyman Co Founder @ Dewpoint Therapeutics
Co Founder

ameet-nathwani_image

Ameet Nathwani
Ameet Nathwani Chief Executive Officer @ Dewpoint Therapeutics
Chief Executive Officer
2020-10-01

michael-fenn_image

Michael Fenn
Michael Fenn Director External Innovation @ Dewpoint Therapeutics
Director External Innovation
2020-01-01

mark-murcko_image

Mark Murcko
Mark Murcko Founding CSO & Member of the Board of Directors @ Dewpoint Therapeutics
Founding CSO & Member of the Board of Directors
2018-11-01

not_available_image

Rebecca Zacks
Rebecca Zacks Vice President, Community and Content @ Dewpoint Therapeutics
Vice President, Community and Content

lori-burrell-escobedo_image

Lori (Burrell) Escobedo
Lori (Burrell) Escobedo Chief People Officer @ Dewpoint Therapeutics
Chief People Officer
2021-09-01

Founder


anthony-hyman_image

Anthony Hyman

richard-young_image

Richard Young

Investors List

softbank-vision-fund_image

SoftBank Vision Fund

SoftBank Vision Fund investment in Series C - Dewpoint Therapeutics

mirae-asset-capital_image

Mirae Asset Capital

Mirae Asset Capital investment in Series C - Dewpoint Therapeutics

polaris-partners_image

Polaris Partners

Polaris Partners investment in Series C - Dewpoint Therapeutics

general-catalyst-partners_image

General Catalyst

General Catalyst investment in Series C - Dewpoint Therapeutics

leaps-by-bayer_image

Leaps by Bayer

Leaps by Bayer investment in Series C - Dewpoint Therapeutics

maverick-ventures_image

Maverick Ventures

Maverick Ventures investment in Series C - Dewpoint Therapeutics

arch-venture-partners_image

ARCH Venture Partners

ARCH Venture Partners investment in Series C - Dewpoint Therapeutics

ns-investment_image

NS Investment

NS Investment investment in Series C - Dewpoint Therapeutics

samsara-biocapital_image

Samsara BioCapital

Samsara BioCapital investment in Series C - Dewpoint Therapeutics

3e-bioventures_image

3E Bioventures

3E Bioventures investment in Series C - Dewpoint Therapeutics

Key Employee Changes

Date New article
2021-09-28 Dewpoint Therapeutics Appoints Lori Escobedo as Chief People Officer

Official Site Inspections

http://www.dewpointx.com Semrush global rank: 2.13 M Semrush visits lastest month: 9.47 K

  • Host name: 169.110.212.35.bc.googleusercontent.com
  • IP address: 35.212.110.169
  • Location: United States
  • Latitude: 38.6583
  • Longitude: -77.2481
  • Timezone: America/New_York

Loading ...

More informations about "Dewpoint Therapeutics" on Search Engine